ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665773 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665773; 2) Community: the network communities that were significantly associated with the response to NSC 665773; 3) Molecule: the relationships between components within communities and NSC 665773; 4) MDR: the compounds that were significantly associated with the NSC 665773.

NSC Compound Enrichment Correlation
NSC 647329 Null 0.0342636096654276 0.20555264
NSC 647395 Null 0.0342636096654276 0.20292259
NSC 654509 Pirarubicin HCl 0.0342636096654276 0.203529
NSC 666571 7.alpha.-Methyl-3,11.beta.,17.beta.-trihydroxy estra-1,3,5(10)triene 11-nitrate ester 0.0385203205529756 0.17645016
NSC 67209 1,4-Naphthoquinone, 2-(methylthio)- (8CI) 0.0385203205529756 0.23930417
NSC 674685 Null 0.0385203205529756 -0.024402257
NSC 682298 Camptothecin Derivative 0.0385203205529756 0.32112601
NSC 684567 4,6(1H,5H)-Pyrimidinedione, 5-[3-[4-(diethylamino)phenyl]- 2-propenylidene]-2,3-dihydro-2-thioxo- 0.0385203205529756 0.3986872
NSC 693543 4-Acridinecarboxamide, 9-amino-N-[3-[(2-aminoethyl)amino]propyl]-5-methyl-, trihydrochloride 0.0385203205529756 0.10589747
NSC 697194 Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- 0.0385203205529756 0.21980246
Total:77  Current:57    [First] [Prev] [Next] [Last]